<VariationArchive VariationID="1032765" VariationName="NM_017780.4(CHD7):c.519del (p.Pro174fs)" VariationType="Deletion" Accession="VCV001032765" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2021-03-22" MostRecentSubmission="2022-08-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1020503" VariationID="1032765">
      <GeneList>
        <Gene Symbol="CHD7" FullName="chromodomain helicase DNA binding protein 7" GeneID="55636" HGNC_ID="HGNC:20626" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="60678740" stop="60868028" display_start="60678740" display_stop="60868028" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="61591323" stop="61780586" display_start="61591323" display_stop="61780586" Strand="+" />
          </Location>
          <OMIM>608892</OMIM>
          <Haploinsufficiency last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD7">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD7">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_017780.4(CHD7):c.519del (p.Pro174fs)</Name>
      <CanonicalSPDI>NC_000008.11:60741950:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="60741951" stop="60741951" display_start="60741951" display_stop="60741951" variantLength="1" positionVCF="60741950" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="61654510" stop="61654510" display_start="61654510" display_stop="61654510" variantLength="1" positionVCF="61654509" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>P174fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_176" sequenceAccession="LRG_176">
            <Expression>LRG_176:g.68172del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.61654510del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.61654510del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.60741951del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.60741951del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007009.1" sequenceAccession="NG_007009" sequenceVersion="1" change="g.68172del">
            <Expression>NG_007009.1:g.68172del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001316690.1" sequenceAccession="NM_001316690" sequenceVersion="1" change="c.519del">
            <Expression>NM_001316690.1:c.519del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001303619.1" sequenceAccession="NP_001303619" sequenceVersion="1" change="p.Pro174fs">
            <Expression>NP_001303619.1:p.Pro174fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017780.4" sequenceAccession="NM_017780" sequenceVersion="4" change="c.519del" MANESelect="true">
            <Expression>NM_017780.4:c.519del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060250.2" sequenceAccession="NP_060250" sequenceVersion="2" change="p.Pro174fs">
            <Expression>NP_060250.2:p.Pro174fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017780.4" sequenceAccession="NM_017780" sequenceVersion="4" change="c.519delT" MANESelect="true">
            <Expression>NM_017780.4:c.519delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1809050272" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_017780.4(CHD7):c.519del (p.Pro174fs) AND Hypogonadotropic hypogonadism 5 with or without anosmia" Accession="RCV001334948" Version="1">
        <ClassifiedConditionList TraitSetID="516">
          <ClassifiedCondition DB="MedGen" ID="C3552553">Hypogonadotropic hypogonadism 5 with or without anosmia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-10-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_017780.4(CHD7):c.519del (p.Pro174fs) AND CHARGE syndrome" Accession="RCV002279736" Version="2">
        <ClassifiedConditionList TraitSetID="513">
          <ClassifiedCondition DB="MedGen" ID="C0265354">CHARGE syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-22" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-03-22" MostRecentSubmission="2022-08-29">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">36135330</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="516" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5355" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Kallmann syndrome 5</ElementValue>
                <XRef ID="Kallmann+syndrome+5/8704" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGONADOTROPIC HYPOGONADISM 5 WITH ANOSMIA</ElementValue>
                <XRef Type="Allelic variant" ID="608892.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608892.0015" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGONADOTROPHIC HYPOGONADISM 5 WITHOUT ANOSMIA</ElementValue>
                <XRef Type="Allelic variant" ID="608892.0014" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypogonadotropic hypogonadism 5 with or without anosmia</ElementValue>
                <XRef ID="MONDO:0012880" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">KAL5</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HH5</ElementValue>
                <XRef Type="MIM" ID="612370" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">CHD7-Related Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., &lt;4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.</Attribute>
                <XRef ID="NBK1334" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000558347" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000334133" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527475" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506067" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556729" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556733" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CHD7-Related GnRH Deficiency (Kallmann Syndrome 5)</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10773" />
                <XRef ID="10773" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301296</ID>
                <ID Source="BookShelf">NBK1117</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301509</ID>
                <ID Source="BookShelf">NBK1334</ID>
              </Citation>
              <XRef ID="478" DB="Orphanet" />
              <XRef ID="C3552553" DB="MedGen" />
              <XRef ID="MONDO:0012880" DB="MONDO" />
              <XRef Type="MIM" ID="612370" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="513" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="886" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hittner Hirsch Kreh syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colobomatous microphthalmia, heart disease, hearing loss, and mental retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARGE ASSOCIATION--COLOBOMA, HEART ANOMALY, CHOANAL ATRESIA, RETARDATION, GENITAL AND EAR ANOMALIES</ElementValue>
                <XRef Type="MIM" ID="214800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">CHARGE syndrome</ElementValue>
                <XRef ID="MONDO:0008965" DB="MONDO" />
                <XRef ID="47535005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Coloboma, heart anomaly, choanal atresia, retardation, genital and ear anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARGE association</ElementValue>
                <XRef ID="47535005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hall-Hittner syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHARGE</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">CHD7 disorder encompasses the entire phenotypic spectrum of heterozygous CHD7 pathogenic variants that includes CHARGE syndrome as well as subsets of features that comprise the CHARGE syndrome phenotype. The mnemonic CHARGE syndrome, introduced in the premolecular era, stands for coloboma, heart defect, choanal atresia, retarded growth and development, genital hypoplasia, ear anomalies (including deafness). Following the identification of the genetic cause of CHD7 disorder, the phenotypic spectrum expanded to include cranial nerve anomalies, vestibular defects, cleft lip and/or palate, hypothyroidism, tracheoesophageal anomalies, brain anomalies, seizures, and renal anomalies. Life expectancy highly depends on the severity of manifestations; mortality can be high in the first few years when severe birth defects (particularly complex heart defects) are present and often complicated by airway and feeding issues. In childhood, adolescence, and adulthood, decreased life expectancy is likely related to a combination of residual heart defects, infections, aspiration or choking, respiratory issues including obstructive and central apnea, and possibly seizures. Despite these complications, the life expectancy for many individuals can be normal.</Attribute>
                <XRef ID="NBK1117" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="29" />
                <XRef ID="29" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301296</ID>
                <ID Source="BookShelf">NBK1117</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21407266</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <XRef ID="138" DB="Orphanet" />
              <XRef ID="C0265354" DB="MedGen" />
              <XRef ID="MONDO:0008965" DB="MONDO" />
              <XRef Type="MIM" ID="214800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3003178" SubmissionDate="2021-03-05" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="NM_017780.3:c.519delT|OMIM:612370" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001527963" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHD7" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017780.3:c.519delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612370" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9201740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5021691" SubmissionDate="2022-08-25" DateLastUpdated="2022-08-29" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="EATEF WES S4|OMIM:214800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002567933" DateUpdated="2022-08-29" DateCreated="2022-08-29" Type="SCV" Version="1" SubmitterName="Daryl Scott Lab, Baylor College of Medicine" OrgID="505993" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHD7" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017780.4:c.519delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="214800" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">36135330</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11958415</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3003178" TraitType="Disease" MappingType="XRef" MappingValue="612370" MappingRef="OMIM">
        <MedGen CUI="C3552553" Name="Hypogonadotropic hypogonadism 5 with or without anosmia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5021691" TraitType="Disease" MappingType="XRef" MappingValue="214800" MappingRef="OMIM">
        <MedGen CUI="C0265354" Name="CHARGE syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

